Multi-cell sealed container

US9987194B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9987194-B2
Application numberUS-201514835757-A
CountryUS
Kind codeB2
Filing dateAug 26, 2015
Priority dateAug 26, 2014
Publication dateJun 5, 2018
Grant dateJun 5, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Described in one aspect is a multi-cell or multi-chambered container for sealing various materials such as therapeutic or diagnostic agents, animal or human tissue, tissue samples, specimens, blood, genetic material, or any other material. The container includes seals formed by folding the wall of the elongate body transverse to the interior of the elongate body and maintaining the folded wall portions adjacent one another or joining them together. In another aspect, the container disclosed may be made according to a method involving creating multiple seals at various locations along the elongate body thus creating sealed voids or cells between the seals within the elongate body.

First claim

Opening claim text (preview).

What is claimed is: 1. A container, comprising: an elongate body with a first, second, and third seal at three separate locations respectively along the elongate body defining a first hermetically sealed void within the elongate body between the first and second seals, and a second hermetically sealed void within the elongate body between the second and third seals; wherein at least one of the first or second hermetically sealed voids contains a therapeutic or diagnostic agent; wherein the elongate body has a wall defining an interior lumen that has an inner surface; wherein the first seal includes a plurality of folds in the wall defining corresponding sealing portions of the wall; wherein the sealing portions extend transverse to the interior lumen; and wherein the sealing portions are joined to one another to form the first seal, and wherein the first seal, the second seal, and/or the third seal each includes at least three folds defining at least three sealing portions per seal, the sealing portions extending transverse to the interior lumen in different directions, and wherein the sealing portions are on the inner surface of the interior lumen. 2. The container of claim 1 , wherein an interior width of the interior lumen at a location adjacent the first, second, or third seal is narrower than the interior width at a location other than adjacent the first, second, and third seal locations. 3. The container of claim 1 , wherein the wall of the elongate member includes a thermoplastic polymeric material. 4. The container of claim 1 , further comprising: a fourth seal at a fourth separate locations along the elongate body defining a third hermetically sealed void within the elongate body between the third and fourth seals; wherein the second hermetically sealed void contains a therapeutic or diagnostic agent; wherein the first and third hermetically sealed voids do not contain a therapeutic or diagnostic agent; and wherein the fourth seal includes at least three folds in the wall defining at least three sealing portions extending transverse to the interior lumen in different directions, and wherein the at least three sealing portions of the fourth seal are fused together to form a unitary structure. 5. The container of claim 1 , wherein the therapeutic or diagnostic agent includes cells. 6. The container of claim 3 , wherein the thermoplastic polymeric material is Ethylene-Vinyl Acetate (EVA). 7. The container of claim 1 , wherein the sealing portions of the wall are contiguous with the wall. 8. A container, comprising: an elongate body with a first, second, and third seal at three separate locations respectively along the elongate body defining a first hermetically sealed void within the elongate body between the first and second seals, and a second hermetically sealed void within the elongate body between the second and third seals; wherein the first hermetically sealed void maintains a sterile puncture site through the second seal into the second hermetically sealed void; wherein the second hermetically sealed void contains a biological material comprising cells; wherein the elongate body has a wall defining an interior lumen that has an inner surface; wherein the first seal includes a plurality of folds in the wall defining corresponding sealing portions of the wall; wherein the sealing portions extend transverse to the interior lumen; wherein the sealing portions are joined to one another to form the first seal; and a fourth seal at a fourth separate location along the elongate body defining a third hermetically sealed void within the elongate body between the third and fourth seals; wherein the third hermetically sealed void maintains a sterile puncture site through the third seal into the second hermetically sealed void and does not contain a therapeutic or diagnostic agent; and wherein the fourth seal includes at least three folds in the wall defining at least three sealing portions extending transverse to the interior lumen in different directions, and wherein the at least three sealing portions of the fourth seal are fused together to form a unitary structure. 9. The container of claim 8 , wherein the wall of the elongate member includes a thermoplastic polymeric material. 10. The container of claim 8 , wherein the sealing portions of the wall are contiguous with the wall.

Assignees

Inventors

Classifications

  • Use of {PU, i.e.} polyureas or polyurethanes {or derivatives thereof}, as moulding material · CPC title

  • A61J1/1406Primary

    Septums, pierceable membranes · CPC title

  • Stretching or tensioning the joint area during joining · CPC title

  • Closing the ends of tubular or hollow single articles, e.g. closing the ends of bags (closing tube ends B29C57/10) · CPC title

  • Containers having several compartments for products to be mixed · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9987194B2 cover?
Described in one aspect is a multi-cell or multi-chambered container for sealing various materials such as therapeutic or diagnostic agents, animal or human tissue, tissue samples, specimens, blood, genetic material, or any other material. The container includes seals formed by folding the wall of the elongate body transverse to the interior of the elongate body and maintaining the folded wall …
Who is the assignee on this patent?
Muffin Inc
What technology area does this patent fall under?
Primary CPC classification A61J1/1406. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jun 05 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).